Proposed Data Collection Submitted for Public Comment and Recommendations: Survey of Engineered Nanomaterial Occupational Safety and Health Practices; Extension of Public Comment Period, 13607-13608 [2017-04942]
Download as PDF
<![CDATA[
Federal Register / Vol. 82, No. 48 / Tuesday, March 14, 2017 / Notices
Office Building, Docket Library, Room
10102, 725 17th Street NW.,
Washington, DC 20503. Comments sent
to OMB by U.S. postal mail, however,
are subject to delays due to heightened
security precautions. Thus, comments
instead should be sent by facsimile to
(202) 395–5167.
David C. Shonka,
Acting General Counsel.
[FR Doc. 2017–04929 Filed 3–13–17; 8:45 am]
BILLING CODE 6750–01–P
GULF COAST ECOSYSTEM
RESTORATION COUNCIL
Notice of Proposed Subaward Under a
Council-Selected Restoration
Component Award
Gulf Coast Ecosystem
Restoration Council.
ACTION: Notice.
AGENCY:
The Gulf Coast Ecosystem
Restoration Council (Council) publishes
notice of a proposed subaward from the
National Oceanic and Atmospheric
Administration National Centers for
Coastal Ocean Science (NOAA) to the
Gulf of Mexico Alliance (GOMA), a
nonprofit organization, for the purpose
of supporting the Council Monitoring
and Assessment Program (CMAP). The
Council and NOAA have entered an
interagency agreement for NOAA to
carry out CMAP, as approved in the
Council’s Initial Funded Priorities List.
FOR FURTHER INFORMATION CONTACT:
Please send questions by email to
raams_pgmsupport@restorethegulf.gov.
SUPPLEMENTARY INFORMATION: Section
1321(t)(2)(E)(ii)(III) of the RESTORE Act
(33 U.S.C. 1321(t) and note) and
Treasury’s implementing regulation at
31 CFR 34.401(b) require that, for
purposes of awards made under the
Council-Selected Restoration
Component, a State or Federal award
recipient may make a grant or subaward
to or enter into a cooperative agreement
with a nongovernmental entity that
equals or exceeds 10 percent of the total
amount of the award provided to the
State or Federal award recipient only if
certain notice requirements are met.
Specifically, at least 30 days before the
State or Federal award recipient enters
into such an agreement, the Council
must publish in the Federal Register
and deliver to specified Congressional
Committees the name of the recipient
and subrecipient; a brief description of
the activity, including its purpose; and
the amount of the award. This notice
accomplishes the Federal Register
publication requirement.
asabaliauskas on DSK3SPTVN1PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:42 Mar 13, 2017
Jkt 241001
Description of Proposed Action
As specified in the Initial Funded
Priorities List, which is available on the
Council’s Web site at https://
www.restorethegulf.gov/councilselected-restoration-component/fundedpriorities-list, RESTORE Act funds will
support the Council Monitoring and
Assessment Program (CMAP).
Administered jointly by NOAA and the
Department of the Interior’s United
States Geological Survey (USGS), CMAP
will build the foundational components
for Gulf region-wide monitoring in order
to measure impacts of investments in
restoration. Through collaboration with
the Gulf States, federal and local
partners, academia, non-governmental/
non-profit organizations, and industry,
the program will use a Monitoring
Community of Practice coordinated by
the Gulf of Mexico Alliance to leverage
existing resources, capacities, and
expertise and build on existing
monitoring programs. These existing
programs will be coordinated into a
network, to provide efficiency in
monitoring and collaborative crossprogram review of performance with
other Gulf ecosystem recovery efforts.
The program will: (1) Create an
inventory of the existing monitoring
programs, data, protocols and standards;
(2) determine the minimum monitoring
elements needed to evaluate the
performance of restoration projects; (3)
evaluate monitoring program suitability;
(4) combine data from the suitable
existing programs into searchable
databases for Council use; (5) examine
the inventory to determine what data
are missing (i.e. identify information
gaps) that would be required for the
RESTORE Council; (6) document
existing baseline assessments of habitat
and water quality conditions; and (7)
provide recommendations to the
Council to supplement and refine the
existing monitoring programs to fill-in
the information gaps where possible.
Will D. Spoon,
Program Analyst, Gulf Coast Ecosystem
Restoration Council.
[FR Doc. 2017–04937 Filed 3–13–17; 8:45 am]
BILLING CODE 6560–58–P
PO 00000
13607
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[Docket No. CDC–2017–0008]
Proposed Data Collection Submitted
for Public Comment and
Recommendations: Survey of
Engineered Nanomaterial Occupational
Safety and Health Practices; Extension
of Public Comment Period
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Extension of public comment
period.
AGENCY:
On February 10, 2017, the
Centers for Disease Control and
Prevention (CDC), located within the
Department of Health and Human
Services (HHS) published a notice in the
Federal Register requesting public
comment on the proposed information
collection entitled ‘‘Survey of
Engineered Nanomaterial Occupational
Safety and Health Practices’’. Written
and electronic comments were to be
received on or before April 11, 2017.
Because of an improper docket opening,
CDC is extending the comment period to
allow the public a full 60 days to
provide comment on this docket. In
consideration of this public access
issue, HHS/CDC is extending the
comment period to May 12, 2017.
DATES: Written comments must be
received on or before May 11, 2017.
ADDRESSES: You may submit comments,
identified by Docket No. CDC–2017–
0008 by any of the following methods:
• Federal eRulemaking Portal:
Regulations.gov. Follow the instructions
for submitting comments.
• Mail: Leroy A. Richardson,
Information Collection Review Office,
Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS–
D74, Atlanta, Georgia 30329.
Instructions: All submissions received
must include the agency name and
Docket Number. All relevant comments
received will be posted without change
to Regulations.gov, including any
personal information provided. For
access to the docket to read background
documents or comments received, go to
Regulations.gov.
SUMMARY:
Please note: All public comment should be
submitted through the Federal eRulemaking
portal (Regulations.gov) or by U.S. mail to the
address listed above.
To
request more information on the
proposed project or to obtain a copy of
FOR FURTHER INFORMATION CONTACT:
Frm 00032
Fmt 4703
Sfmt 4703
E:\FR\FM\14MRN1.SGM
14MRN1
13608
Federal Register / Vol. 82, No. 48 / Tuesday, March 14, 2017 / Notices
the information collection plan and
instruments, contact the Information
Collection Review Office, Centers for
Disease Control and Prevention, 1600
Clifton Road NE., MS–D74, Atlanta,
Georgia 30329; phone: 404–639–7570;
Email: omb@cdc.gov.
Under the
Paperwork Reduction Act of 1995 (PRA)
(44 U.S.C. 3501–3520), Federal agencies
must obtain approval from the Office of
Management and Budget (OMB) for each
collection of information they conduct
or sponsor. In addition, the PRA also
requires Federal agencies to provide
notice in the Federal Register
concerning each proposed collection of
information, including each new
proposed collection, each proposed
extension of existing collection of
information, and each reinstatement of
previously approved information
collection before submitting the
collection to OMB for approval.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) The accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
Ways to enhance the quality, utility, and
clarity of the information to be
collected; (d) Ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology; and (e) Estimates of capital
or start-up costs and costs of operation,
maintenance, and purchase of services
to provide information. Burden means
the total time, effort, or financial
resources expended by persons to
generate, maintain, retain, disclose or
provide information to or for a Federal
agency. This includes the time needed
to review instructions; to develop,
acquire, install and utilize technology
and systems for the purpose of
collecting, validating and verifying
information, processing and
maintaining information, and disclosing
and providing information; to train
personnel and to be able to respond to
a collection of information, to search
data sources, to complete and review
the collection of information; and to
SUPPLEMENTARY INFORMATION:
asabaliauskas on DSK3SPTVN1PROD with NOTICES
transmit or otherwise disclose the
information.
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–04942 Filed 3–13–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2017–N–1062]
Joint Meeting of the Anesthetic and
Analgesic Drug Products Advisory
Committee and the Drug Safety and
Risk Management Advisory
Committee; Notice of Meeting;
Establishment of a Public Docket;
Request for Comments
AGENCY:
Food and Drug Administration,
HHS.
Notice; establishment of a
public docket; request for comments.
ACTION:
The Food and Drug
Administration (FDA) announces a
forthcoming public advisory committee
meeting of the Anesthetic and Analgesic
Drug Products Advisory Committee and
the Drug Safety and Risk Management
Advisory Committee. The general
function of the committees is to provide
advice and recommendations to the
Agency on FDA’s regulatory issues. At
least one portion of the meeting will be
closed to the public. FDA is establishing
a docket for public comment on this
document.
SUMMARY:
The meeting will be held on
April 5, 2017, from 8 a.m. to 5 p.m.
ADDRESSES: Tommy Douglas Conference
Center, the Ballroom, 10000 New
Hampshire Ave., Silver Spring, MD
20903. The conference center’s
telephone number is 240–645–4000.
Answers to commonly asked questions
including information regarding special
accommodations due to a disability,
visitor parking, and transportation may
be accessed at: https://www.fda.gov/
AdvisoryCommittees/
AboutAdvisoryCommittees/
ucm408555.htm. You may submit
comments as follows:
DATES:
Electronic Submissions
Submit electronic comments in the
following way:
• Federal eRulemaking Portal:
https://www.regulations.gov. Follow the
instructions for submitting comments.
VerDate Sep<11>2014
17:42 Mar 13, 2017
Jkt 241001
PO 00000
Frm 00033
Fmt 4703
Sfmt 4703
Comments submitted electronically,
including attachments, to https://
www.regulations.gov will be posted to
the docket unchanged. Because your
comment will be made public, you are
solely responsible for ensuring that your
comment does not include any
confidential information that you or a
third party may not wish to be posted,
such as medical information, your or
anyone else’s Social Security number, or
confidential business information, such
as a manufacturing process. Please note
that if you include your name, contact
information, or other information that
identifies you in the body of your
comments, that information will be
posted on https://www.regulations.gov.
• If you want to submit a comment
with confidential information that you
do not wish to be made available to the
public, submit the comment as a
written/paper submission and in the
manner detailed (see ‘‘Written/Paper
Submissions’’ and ‘‘Instructions’’).
Written/Paper Submissions
Submit written/paper submissions as
follows:
• Mail/Hand delivery/Courier (for
written/paper submissions): Division of
Dockets Management (HFA–305), Food
and Drug Administration, 5630 Fishers
Lane, Rm. 1061, Rockville, MD 20852.
• For written/paper comments
submitted to the Division of Dockets
Management, FDA will post your
comment, as well as any attachments,
except for information submitted,
marked and identified, as confidential,
if submitted as detailed in
‘‘Instructions.’’
Instructions: All submissions received
must include the Docket No. FDA–
2017–N–1062 for ‘‘Joint Meeting of the
Anesthetic and Analgesic Drug Products
Advisory Committee and the Drug
Safety and Risk Management Advisory
Committee; Notice of Meeting;
Establishment of a Public Docket;
Request for Comments.’’ Received
comments will be placed in the docket
and, except for those submitted as
‘‘Confidential Submissions,’’ publicly
viewable at https://www.regulations.gov
or at the Division of Dockets
Management between 9 a.m. and 4 p.m.,
Monday through Friday.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
E:\FR\FM\14MRN1.SGM
14MRN1
]]>Agencies
[Federal Register Volume 82, Number 48 (Tuesday, March 14, 2017)]
[Notices]
[Pages 13607-13608]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-04942]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Docket No. CDC-2017-0008]
Proposed Data Collection Submitted for Public Comment and
Recommendations: Survey of Engineered Nanomaterial Occupational Safety
and Health Practices; Extension of Public Comment Period
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Extension of public comment period.
-----------------------------------------------------------------------
SUMMARY: On February 10, 2017, the Centers for Disease Control and
Prevention (CDC), located within the Department of Health and Human
Services (HHS) published a notice in the Federal Register requesting
public comment on the proposed information collection entitled ``Survey
of Engineered Nanomaterial Occupational Safety and Health Practices''.
Written and electronic comments were to be received on or before April
11, 2017. Because of an improper docket opening, CDC is extending the
comment period to allow the public a full 60 days to provide comment on
this docket. In consideration of this public access issue, HHS/CDC is
extending the comment period to May 12, 2017.
DATES: Written comments must be received on or before May 11, 2017.
ADDRESSES: You may submit comments, identified by Docket No. CDC-2017-
0008 by any of the following methods:
Federal eRulemaking Portal: Regulations.gov. Follow the
instructions for submitting comments.
Mail: Leroy A. Richardson, Information Collection Review
Office, Centers for Disease Control and Prevention, 1600 Clifton Road
NE., MS-D74, Atlanta, Georgia 30329.
Instructions: All submissions received must include the agency name
and Docket Number. All relevant comments received will be posted
without change to Regulations.gov, including any personal information
provided. For access to the docket to read background documents or
comments received, go to Regulations.gov.
Please note: All public comment should be submitted through the
Federal eRulemaking portal (Regulations.gov) or by U.S. mail to the
address listed above.
FOR FURTHER INFORMATION CONTACT: To request more information on the
proposed project or to obtain a copy of
[[Page 13608]]
the information collection plan and instruments, contact the
Information Collection Review Office, Centers for Disease Control and
Prevention, 1600 Clifton Road NE., MS-D74, Atlanta, Georgia 30329;
phone: 404-639-7570; Email: omb@cdc.gov.
SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995
(PRA) (44 U.S.C. 3501-3520), Federal agencies must obtain approval from
the Office of Management and Budget (OMB) for each collection of
information they conduct or sponsor. In addition, the PRA also requires
Federal agencies to provide notice in the Federal Register concerning
each proposed collection of information, including each new proposed
collection, each proposed extension of existing collection of
information, and each reinstatement of previously approved information
collection before submitting the collection to OMB for approval.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) The accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) Ways to enhance the quality,
utility, and clarity of the information to be collected; (d) Ways to
minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology; and (e) Estimates of capital or start-
up costs and costs of operation, maintenance, and purchase of services
to provide information. Burden means the total time, effort, or
financial resources expended by persons to generate, maintain, retain,
disclose or provide information to or for a Federal agency. This
includes the time needed to review instructions; to develop, acquire,
install and utilize technology and systems for the purpose of
collecting, validating and verifying information, processing and
maintaining information, and disclosing and providing information; to
train personnel and to be able to respond to a collection of
information, to search data sources, to complete and review the
collection of information; and to transmit or otherwise disclose the
information.
Leroy A. Richardson,
Chief, Information Collection Review Office, Office of Scientific
Integrity, Office of the Associate Director for Science, Office of the
Director, Centers for Disease Control and Prevention.
[FR Doc. 2017-04942 Filed 3-13-17; 8:45 am]
BILLING CODE 4163-18-P
